Alexandre Perrier
Impact in
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Co-authors
- Mathieu Boissan (4 shared papers)Guillaume Lefèvre (2 shared papers)Joseph Gligorov (2 shared papers)Pierre Laurent‐Puig (3 shared papers)Hélène Blons (3 shared papers)Simon Garinet (3 shared papers)Audrey Didelot (3 shared papers)Laure Gibault (1 shared paper)
- Journals
- PLoS ONE (2 papers)Oncogene (1 paper)Frontiers in Oncology (1 paper)ESMO Open (1 paper)Biomolecules (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
Alexandre Perrier
17 papers receiving 225 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 48
- Oncology 70
- Molecular Biology 101
- Immunology 22
- Pulmonary and Respiratory Medicine 32
Countries citing papers authored by Alexandre Perrier
This map shows the geographic impact of Alexandre Perrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Perrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Perrier more than expected).
Fields of papers citing papers by Alexandre Perrier
This network shows the impact of papers produced by Alexandre Perrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Perrier. The network helps show where Alexandre Perrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexandre Perrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2018 | 71 | |
| 3 | 2021 | 22 | |
| 4 | 2020 | 18 | |
| 5 | 2021 | 10 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2019 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | [Atrial fibrillation and obstructive sleep apnea: a fortuitous association?]. | 2014 | 1 |
| 16 | 2004 | 1 | |
| 17 | [Nesiritide in heart failure: commercial success or therapeutic advance?]. | 2006 | 1 |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Alexandre Perrier
Alexandre Perrier is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 19 papers that have together received 228 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Genomic variations and chromosomal abnormalities (2 papers), HER2/EGFR in Cancer Research (2 papers), Genetic factors in colorectal cancer (2 papers), DNA Repair Mechanisms (1 paper), Ferroptosis and cancer prognosis (1 paper), Ubiquitin and proteasome pathways (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Cancer Research (48 citations), Oncology (70 citations), Molecular Biology (101 citations), Immunology (22 citations) and Pulmonary and Respiratory Medicine (32 citations). Alexandre Perrier has collaborated with scholars based in France and Switzerland. Frequent co-authors include Mathieu Boissan, Guillaume Lefèvre, Joseph Gligorov, Pierre Laurent‐Puig, Hélène Blons, Simon Garinet, Audrey Didelot, Laure Gibault, Pierre‐Jean Lamy and Jérôme Alexandre Denis. Their work appears in journals such as PLoS ONE, Oncogene, Frontiers in Oncology, ESMO Open and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.